Annual Drug Patent Expirations for XERMELO
Xermelo is a drug marketed by Tersera and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
This drug has sixty-one patent family members in twenty-nine countries.
The generic ingredient in XERMELO is telotristat etiprate. Two suppliers are listed for this compound. Additional details are available on the telotristat etiprate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
